FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1776457637> ?p ?o ?g. }

• W1776457637 endingPage "343" @default.
• W1776457637 startingPage "337" @default.
• W1776457637 abstract "Interferon-free therapy for hepatitis C virus (HCV) infection is costly, and therefore patients with advanced fibrosis are prioritized. Although coupled with considerable side effects, a large proportion of genotype 2/3 infected patients achieve a sustained virological response (SVR) following interferon-based therapy. The present study evaluates experimental clinical trial and verifying real-life data with the aim of identifying patients with a high likelihood of favorable outcome following short interferon-based treatment.The impact of established response predictors, e.g. age, ITPA and IL28B genetic variants, IP-10, liver histopathology and early viral kinetics on outcome was evaluated among HCV genotype 2/3 infected patients enrolled in the NORDynamIC trial. Similarly outcome was evaluated among Finnish and Swedish real-life genotype 2/3 infected patients treated for 12-16 weeks in accordance with national guidelines.In the NORDynamIC trial, age < 40 years or achieving HCV RNA < 1000 IU/mL day 7 were highly predictive of favorable outcome following 12 weeks therapy. Among 255 Finnish real-life patients below the age of 40 years treated for 12 weeks with interferon and ribavirin, 87% of HCV genotype 2 and 79% of genotype 3 infected patients achieved SVR, and among 117 Swedish real-life patients treated for 12-16 weeks, 97% of HCV genotype 2 and 94% of genotype 3 infected achieved SVR.Short interferon-based therapy offers a high likelihood of achieving SVR for selected HCV genotype 2/3 infected patients, and is an acceptable option given that a thorough discussion of the side effects is provided prior to initiation." @default.
• W1776457637 created "2016-06-24" @default.
• W1776457637 creator A5001187106 @default.
• W1776457637 creator A5008048310 @default.
• W1776457637 creator A5014653589 @default.
• W1776457637 creator A5016043813 @default.
• W1776457637 creator A5021282558 @default.
• W1776457637 creator A5023205753 @default.
• W1776457637 creator A5026830984 @default.
• W1776457637 creator A5030795201 @default.
• W1776457637 creator A5058309698 @default.
• W1776457637 creator A5064373085 @default.
• W1776457637 creator A5065139294 @default.
• W1776457637 creator A5066772724 @default.
• W1776457637 creator A5068330220 @default.
• W1776457637 creator A5069432660 @default.
• W1776457637 creator A5070897081 @default.
• W1776457637 creator A5086019951 @default.
• W1776457637 creator A5088596019 @default.
• W1776457637 creator A5090166045 @default.
• W1776457637 date "2015-09-29" @default.
• W1776457637 modified "2023-10-17" @default.
• W1776457637 title "Short interferon and ribavirin treatment for HCV genotype 2 or 3 infection: NORDynamIC trial and real-life experience" @default.
• W1776457637 cites W1971480291 @default.
• W1776457637 cites W1980771473 @default.
• W1776457637 cites W1981900811 @default.
• W1776457637 cites W1981999858 @default.
• W1776457637 cites W1984101615 @default.
• W1776457637 cites W1992692012 @default.
• W1776457637 cites W1995972074 @default.
• W1776457637 cites W2006919347 @default.
• W1776457637 cites W2022700796 @default.
• W1776457637 cites W2023648193 @default.
• W1776457637 cites W2040976734 @default.
• W1776457637 cites W2054144404 @default.
• W1776457637 cites W2055476022 @default.
• W1776457637 cites W2078251659 @default.
• W1776457637 cites W2079315402 @default.
• W1776457637 cites W2089548045 @default.
• W1776457637 cites W2090754828 @default.
• W1776457637 cites W2109235725 @default.
• W1776457637 cites W2112876622 @default.
• W1776457637 cites W2120733999 @default.
• W1776457637 cites W2147326489 @default.
• W1776457637 cites W2414640396 @default.
• W1776457637 cites W4211051574 @default.
• W1776457637 doi "https://doi.org/10.3109/00365521.2015.1087588" @default.
• W1776457637 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4732462" @default.
• W1776457637 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26418670" @default.
• W1776457637 hasPublicationYear "2015" @default.
• W1776457637 type Work @default.
• W1776457637 sameAs 1776457637 @default.
• W1776457637 citedByCount "13" @default.
• W1776457637 countsByYear W17764576372015 @default.
• W1776457637 countsByYear W17764576372016 @default.
• W1776457637 countsByYear W17764576372017 @default.
• W1776457637 countsByYear W17764576372018 @default.
• W1776457637 countsByYear W17764576372019 @default.
• W1776457637 countsByYear W17764576372020 @default.
• W1776457637 countsByYear W17764576372021 @default.
• W1776457637 crossrefType "journal-article" @default.
• W1776457637 hasAuthorship W1776457637A5001187106 @default.
• W1776457637 hasAuthorship W1776457637A5008048310 @default.
• W1776457637 hasAuthorship W1776457637A5014653589 @default.
• W1776457637 hasAuthorship W1776457637A5016043813 @default.
• W1776457637 hasAuthorship W1776457637A5021282558 @default.
• W1776457637 hasAuthorship W1776457637A5023205753 @default.
• W1776457637 hasAuthorship W1776457637A5026830984 @default.
• W1776457637 hasAuthorship W1776457637A5030795201 @default.
• W1776457637 hasAuthorship W1776457637A5058309698 @default.
• W1776457637 hasAuthorship W1776457637A5064373085 @default.
• W1776457637 hasAuthorship W1776457637A5065139294 @default.
• W1776457637 hasAuthorship W1776457637A5066772724 @default.
• W1776457637 hasAuthorship W1776457637A5068330220 @default.
• W1776457637 hasAuthorship W1776457637A5069432660 @default.
• W1776457637 hasAuthorship W1776457637A5070897081 @default.
• W1776457637 hasAuthorship W1776457637A5086019951 @default.
• W1776457637 hasAuthorship W1776457637A5088596019 @default.
• W1776457637 hasAuthorship W1776457637A5090166045 @default.
• W1776457637 hasBestOaLocation W17764576371 @default.
• W1776457637 hasConcept C104317684 @default.
• W1776457637 hasConcept C126322002 @default.
• W1776457637 hasConcept C135763542 @default.
• W1776457637 hasConcept C203014093 @default.
• W1776457637 hasConcept C2522874641 @default.
• W1776457637 hasConcept C2776178377 @default.
• W1776457637 hasConcept C2776408679 @default.
• W1776457637 hasConcept C2776455275 @default.
• W1776457637 hasConcept C2780040827 @default.
• W1776457637 hasConcept C2781228144 @default.
• W1776457637 hasConcept C2909179924 @default.
• W1776457637 hasConcept C535046627 @default.
• W1776457637 hasConcept C55493867 @default.
• W1776457637 hasConcept C71924100 @default.
• W1776457637 hasConcept C86803240 @default.
• W1776457637 hasConcept C90924648 @default.
• W1776457637 hasConceptScore W1776457637C104317684 @default.
• W1776457637 hasConceptScore W1776457637C126322002 @default.

• next